Clinical Effects of Oral Valiltramiprosate Treatment in APOE4 Carriers with Mild Cognitive Impairment (MCI): Results of the Phase 2 Study Long-term Extension over 3 Years

valiltramiprosate (ALZ-801) - Alzheon

https://www.aan.com/msa/Public/Events/AbstractDetails/63913

Susan Abushakra1; J Patrick Kesslak1; Jakub Hort2; Jeremy Yu1; Jean F Schaefer1; Adem Albayrak3; Margaret Bray1; Luc Bracoud4; Chris Conklin4; Joyce Suhy5; Aidan Power3; Martin Tolar3; John A Hey1

Mar 6, 2026